A financing (not a CR as such) provided by a BP has some contractual obligations and would have some conditional lock out effect on competitors.
Biotron may be somewhat different from others because of the potential for a broad brush general use antiviral treatment. This, we are yet to find out.
Then there is the potential of others in the cupboard.
$10 Billion Deal, page-12667
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.8¢ |
Change
-0.002(4.00%) |
Mkt cap ! $43.30M | |||
| Open | High | Low | Value | Volume |
| 4.9¢ | 5.0¢ | 4.8¢ | $13.69K | 278.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 50000 | 4.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.0¢ | 46070 | 1 |
View Market Depth
| Last trade - 15.37pm 17/06/2024 (20 minute delay) ? |
|
|||||
|
Last
5.0¢ |
Change
-0.002 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 4.9¢ | 5.0¢ | 4.9¢ | 61814 | ||
| Last updated 13.21pm 17/06/2024 ? | |||||
| BIT (ASX) Chart |
